132 related articles for article (PubMed ID: 35644860)
1. RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma.
Gombodorj N; Azuma Y; Yokobori T; Erkhem-Ochir B; Kosaka T; Ohtaki Y; Nakazawa S; Mogi A; Yajima T; Kuwano H; Saeki H; Shirabe K
Ann Surg Oncol; 2022 Oct; 29(11):7149-7162. PubMed ID: 35644860
[TBL] [Abstract][Full Text] [Related]
2. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
3. Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma.
Kim HR; Kang HN; Shim HS; Kim EY; Kim J; Kim DJ; Lee JG; Lee CY; Hong MH; Kim SM; Kim H; Pyo KH; Yun MR; Park HJ; Han JY; Youn HA; Ahn MJ; Paik S; Kim TM; Cho BC
Ann Oncol; 2017 Jun; 28(6):1250-1259. PubMed ID: 28460066
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma.
Pang H; Xu X; Dai L; Wang K; Yao X
Mol Med Rep; 2018 Apr; 17(4):5283-5291. PubMed ID: 29393451
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
Zhang F; Cao H
Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
[TBL] [Abstract][Full Text] [Related]
7. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
Zhao XD; Zhang W; Liang HJ; Ji WY
PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
[TBL] [Abstract][Full Text] [Related]
9. HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis.
Song X; Liao Z; Zhou C; Lin R; Lu J; Cai L; Tan X; Zeng W; Lu X; Zheng W; Chen J; Su Z
Oncol Rep; 2017 Oct; 38(4):2444-2452. PubMed ID: 28849239
[TBL] [Abstract][Full Text] [Related]
10. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
Zhao X; Zhang W; Ji W
Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
12. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
13. [The effect of miR-497 on laryngeal squamous cell carcinoma invasion through modulating PlexinA4].
Niu JT; Liu SG; Huang YW; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):124-130. PubMed ID: 29429182
[No Abstract] [Full Text] [Related]
14. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
[TBL] [Abstract][Full Text] [Related]
15. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.
Yang S; Wang J; Ge W; Jiang Y
J Cell Biochem; 2018 Aug; 119(8):6953-6960. PubMed ID: 29737563
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and functional roles of EIF4G1 in lung squamous cell carcinoma.
Bai B; Dong L; Feng M; Zhang Z; Lu Y; Xu Z; Liu Y
Hum Cell; 2023 May; 36(3):1099-1107. PubMed ID: 36897548
[TBL] [Abstract][Full Text] [Related]
18. Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer.
Mäkinen N; Meyerson M
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37909331
[TBL] [Abstract][Full Text] [Related]
19. Expression of polysialic acid in primary laryngeal squamous cell carcinoma.
Klobučar M; Visentin S; Jakovčević A; Bilić M; Kovač-Bilić L; Đanić D; Pavelić K; Kraljević Pavelić S
Life Sci; 2017 Mar; 173():73-79. PubMed ID: 28185819
[TBL] [Abstract][Full Text] [Related]
20. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
Zhang X; Kong M; Zhang Z; Xu S; Yan F; Wei L; Zhou J
Thorac Cancer; 2017 Nov; 8(6):655-665. PubMed ID: 28906590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
